0
0
1/11/26 at 8:00pm
Organization
FDA.gov
Author
Office of the Commissioner
48 words
0
Comments
The U.S. Food and Drug Administration today announced it is sharing information about the agency’s flexible approach to overseeing chemistry, manufacturing and control (CMC) requirements for cell and gene therapies (CGT).
You are the first to view
https://www.fda.gov/news-events/press-announcements/fda-increases-flexibility-requirements-cell-and-gene-therapies-advance-innovation
Create an account
or login to join the discussion